Improvement in renal blood flow and kidney function by modulation of prostaglandin metabolism in cyclosporine-treated animals
- PMID: 2784912
Improvement in renal blood flow and kidney function by modulation of prostaglandin metabolism in cyclosporine-treated animals
Similar articles
-
Cyclosporine-associated toxicity in pancreatic islet cells and its prevention by K-MAP in cyclosporine-treated animals.Transplant Proc. 1989 Feb;21(1 Pt 3):2774-9. Transplant Proc. 1989. PMID: 2650362 No abstract available.
-
Prevention of cyclosporine-associated nephrotoxicity by K-MAP.Transplant Proc. 1988 Feb;20(1 Suppl 1):179-82. Transplant Proc. 1988. PMID: 3279608 No abstract available.
-
Stimulation of intrinsic prostacyclin synthesis and inhibition of thromboxane production to minimize cyclosporine nephrotoxicity.Transplant Proc. 1988 Jun;20(3 Suppl 3):638-45. Transplant Proc. 1988. PMID: 3291300 No abstract available.
-
Cyclosporine nephrotoxicity: studies in laboratory animals.Transplant Proc. 1985 Aug;17(4 Suppl 1):145-54. Transplant Proc. 1985. PMID: 3895655 Review. No abstract available.
-
[Renal functional effects of non-steroidal anti-inflammatory agents and prostaglandins].Nephrologie. 1988;9(3):125-8. Nephrologie. 1988. PMID: 3057393 Review. French.
Cited by
-
Prevention and management of graft-versus-host disease. Practical recommendations.Drugs. 1993 May;45(5):668-76. doi: 10.2165/00003495-199345050-00004. Drugs. 1993. PMID: 7686462 Review.
-
Clinically significant drug interactions with cyclosporin. An update.Clin Pharmacokinet. 1996 Feb;30(2):141-79. doi: 10.2165/00003088-199630020-00004. Clin Pharmacokinet. 1996. PMID: 8906896 Review.